And, as it turns out, fiber is pretty essential for your overall health—supporting everything from your digestion to your microbiome, yet most of us aren’t getting nearly enou ...

Each brand has its own formula for helping users achieve their weight loss goals. Their methods include remote healthcare ...

But hCG is not approved for weight loss and there’s no evidence it helps. The U.S. FDA warns against its use, saying that very restrictive diets, such as the hCG diet, are dangerous. The history ...

Retatrutide — an experimental drug nicknamed “triple G” — could be your best shot at a slimmer ... the US Food and Drug Administration (FDA) has approved for weight loss and nine it ...

The Food and Drug Administration (FDA) gave the green light ... in combination with a reduced-calorie diet and increased physical activity. “Today’s approval marks the first drug treatment ...

After delay, Roche's Tecentriq Hybreza wins first FDA approval for a subcutaneous PD-L1 drug Opdivo Qvantig’s average administration time of less than five minutes was observed in the Checkmate ...

The Cabinet approved a special package for companies manufacturing DAP fertiliser. This initiative includes financial assistance in addition to the existing subsidies for DAP producers. “ ...

The drug has been specifically approved for adults with moderate-to-severe obstructive sleep apnea and obesity. Its use is recommended alongside increased exercise and a lower-calorie diet.

The FDA’s Center for Drug Evaluation and Research (CDER) approved 50 new small molecules, biologics and oligonucleotide therapeutics last year. The class of 2024 was a little smaller than that ...

For many people, the end of the year is a mad rush to wrap things up before the holidays, and so it was for the FDA. Notable regulatory decisions include the first drug approval for a prevalent ...

1 "We are pleased Opdivo Qvantig, which is co-formulated with our Enhanze drug delivery technology, is now FDA-approved as the first and only subcutaneously administered PD-1 inhibitor in the US ...

Opdivo was previously only available as a solution for intravenous (IV) infusion. The approval of Opdivo Qvantig was supported by data from the randomized, open-label phase 3 CheckMate-67T study ...